Showing 1 - 2 results of 2 for search 'Spanish Group of Chronic Myeloid Leukemia (GELMC)', query time: 0.03s Refine Results
  1. 1
    A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia.

    A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia. by Valentín García-Gutiérrez, María T Gómez-Casares, José M Puerta, Juan M Alonso-Domínguez, Santiago Osorio, Juan C Hernández-Boluda, Rosa Collado, María J Ramírez, Fátima Ibáñez, María L Martín, Juan D Rodríguez-Gambarte, Carolina Martínez-Laperche, Montse Gómez, Dolly V Fiallo, Sara Redondo, Alicia Rodríguez, Concepción Ruiz-Nuño, Juan L Steegmann, Antonio Jiménez-Velasco, Spanish Group of Chronic Myeloid Leukemia (GELMC)

    Published 2017-01-01
    Get full text
    Article
  2. 2
    S153: MECHANISMS OF TROMBOGENESIS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDER TREATMENT WITH PONATINIB AND OTHER TYROSINE KINASE INHIBITORS

    S153: MECHANISMS OF TROMBOGENESIS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDER TREATMENT WITH PONATINIB AND OTHER TYROSINE KINASE INHIBITORS by Ernesto José Cuenca Zamora, Sonia Águila, María José Lis, Maria Carmen Garcia Hernandez, María Jose Fernández, María Soledad Noya Pereira, Elvira Mora Castera, Luis Palomera Bernal, Maria Alicia Senin Magan, Raúl Pérez López, Manuel Perez Encinas, Anna Angona Figueras, José Manuel Puerta, Rolando Vallansot, Venancio Conesa Garcia, Juan Carlos Hernandez-Boluda, Ana Rosell Mas, Montserrat Cortés, Guillermo Ortí, Blanca Xicoy Cirici, Gonzalo Carreño Gomez-Tarragona, Pilar Giraldo, Maria L Lozano, Valentin Garcia Gutierrez, Francisca Ferrer-Marín, On Behalf of Spanish Group of Chronic Myeloid Leukemia (Gelmc)

    Published 2023-08-01
    Get full text
    Article

Search Tools: